G-Protein Coupled Receptors Market by Product Type, End-Users, and Geography (North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa): Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2030

Description

Persistence Market Research has conducted a thorough analysis of the G-Protein Coupled Receptors Market, providing a comprehensive report detailing its global landscape. This in-depth publication offers valuable insights into the market's dynamics, trends, opportunities, and challenges, providing a comprehensive overview of its structure. Backed by exclusive data and statistics, the research predicts the anticipated growth trajectory of the G-Protein Coupled Receptors Market spanning from 2023 to 2030.

The worldwide G-Protein coupled receptors (GPCR) market is expected to grow steadily at a compound annual growth rate (CAGR) of 5.4%. This growth trajectory would elevate the market from its 2023 value of US$3.6 billion to an estimated US$5.2 billion by the conclusion of 2030.

Key Insights:

G-Protein Coupled Receptors Market Size (2023E): US$3.6 B
Projected Market Value (2030F): US$5.2 Bn
Global Market Growth Rate (CAGR 2023 to 2030): 5.4%
Historical Market Growth Rate (CAGR 2018 to 2022): 5.0%

G-Protein Coupled Receptors Market - Report Scope

G-protein coupled receptors (GPCRs) are integral membrane proteins crucial for signal transduction across cells. They regulate various physiological processes and are key targets for pharmaceuticals treating conditions like hypertension and neurological disorders. The global GPCR market is expanding due to intensified research into chronic diseases, advancements in genomics and biotechnology, emphasis on personalized medicine, and continuous technological improvements facilitating drug discovery.

Market Growth Drivers

Pharmaceutical research is increasingly targeting G-protein coupled receptors (GPCRs) due to their vital role in transmitting signals across cell membranes, regulating physiological processes. Around 30% to 40% of all commercially available drugs target GPCRs, reflecting their significance in addressing various ailments like neurological disorders, cardiovascular diseases, and cancer. With the rising global incidence of chronic diseases, including cardiovascular issues, GPCRs offer promising avenues for developing new therapies. Their impact on cardiovascular regulation, affecting variables like blood pressure and heart rate, makes them attractive targets for drugs addressing conditions such as hypertension and heart failure. Moreover, GPCRs influence immune response, sensory perception, and neurotransmission, further driving research into targeted therapeutic interventions as novel associations between GPCRs and diseases are discovered.

Market Restraints

The intricate and diverse nature of G-protein coupled receptors (GPCRs) poses significant challenges to the pharmaceutical research market. GPCRs comprise a vast family of receptors with numerous subtypes, each capable of triggering unique cellular responses. This complexity makes it challenging to develop medications that specifically target GPCR subtypes without causing unintended side effects. Additionally, the involvement of GPCRs in a wide range of physiological processes, as well as their association with complex disorders such as cancer and neurodegenerative diseases, further complicates the development of targeted treatments. Achieving therapeutic efficacy while minimizing adverse effects requires a deep understanding of GPCR biology and signaling pathways, making drug design and development a formidable task in this field.

Opportunities

The integration of machine learning (ML) and Artificial Intelligence (AI) in drug discovery is driving advancements in the global market for G-protein coupled receptors (GPCRs). These technologies enable efficient analysis of large datasets, prediction of pharmaceutical candidates, and optimization of molecular structures, significantly accelerating the drug discovery pipeline. Particularly beneficial in virtual screening, AI and ML algorithms swiftly identify compounds with high binding potential to specific GPCR targets, streamlining the initial stages of drug discovery. Moreover, by predicting interactions between compounds and GPCRs, these technologies enhance drug design accuracy, facilitating the development of more effective and safer medications. Overall, the data-driven approach saves time and resources compared to traditional trial-and-error methods, fostering innovation in GPCR-focused drug discovery.

Key Questions Answered in Report::

What is the current size and projected growth rate of the global G-protein coupled receptors (GPCRs) market?
What are the main factors driving the expansion of the GPCR market worldwide?
What are the key challenges facing the development of pharmaceuticals targeting GPCRs?
How is machine learning (ML) and Artificial Intelligence (AI) being utilized in GPCR-focused drug discovery?
What are the potential therapeutic applications of GPCR-targeted medications?
What are the major trends shaping the landscape of GPCR research and development?

Competitive Intelligence and Business Strategy

Leading entities in the G-protein coupled receptors (GPCRs) industry are driving market dominance through intensive research, strategic collaborations, and the integration of cutting-edge technologies like machine learning (ML) and artificial intelligence (AI). These approaches expedite the discovery and development of innovative GPCR-targeted pharmaceuticals, ensuring a competitive edge in the market.

Key Companies Profiled

Thermo Fisher Scientific Inc.
Eurofins Scientific
QIAGEN
WuXi AppTec
Promega Corporation
Abcam plc
Merck KGaA
PerkinElmer Inc.
Enzo Biochem Inc.
Becton, Dickinson and Company

G-Protein Coupled Receptors Market Segmentation

By Product:

Cell Lines
Detection Kits
Cell Culture Reagents
Ligands

By Assay Type:

cAMP Functional Assays
Calcium Functional Assays
B-Arrestin Functional Assays
Radioligand Binding & GTPγS Functional Assays
Internalization Assays
Trafficking Assays
Other Assays

By Application:

Cancer Research
CNS Research
Metabolic Research
Cardiovascular Research
Respiratory Research
Inflammation Research
Other Applications

By Region:

North America
Europe
East Asia
South Asia & Oceania
Latin America
Middle East & Africa

Product Code: PMRREP33950

1. Executive Summary

1.1. Global G-Protein Coupled Receptors Market Snapshot, 2023 and 2030
1.2. Market Opportunity Assessment, 2023 - 2030, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations

2. Market Overview

2.1. Market Scope and Definition
2.2. Market Dynamics
- 2.2.1. Drivers
- 2.2.2. Restraints
- 2.2.3. Opportunity
- 2.2.4. Challenges
- 2.2.5. Key Trends
2.3. Product Lifecycle Analysis
2.4. G-Protein Coupled Receptors Market: Value Chain
- 2.4.1. List of Raw Material Supplier
- 2.4.2. List of Manufacturers
- 2.4.3. List of Distributors
- 2.4.4. List of Applications
- 2.4.5. Profitability Analysis
2.5. Porter Five Force's Analysis
2.6. Geopolitical Tensions: Market Impact
2.7. Macro-Economic Factors
- 2.7.1. Global Sectorial Outlook
- 2.7.2. Global GDP Growth Outlook
- 2.7.3. Global Parent Market Overview
2.8. Forecast Factors - Relevance and Impact
2.9. Regulatory and Technology Landscape

3. Global G-Protein Coupled Receptors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

3.1. Key Highlights
- 3.1.1. Market Volume (Units) Projections
- 3.1.2. Market Size and Y-o-Y Growth
- 3.1.3. Absolute $ Opportunity
3.2. Market Size (US$ Mn) Analysis and Forecast
- 3.2.1. Historical Market Size Analysis, 2013-2016
- 3.2.2. Current Market Size Forecast, 2018-2026
3.3. Global G-Protein Coupled Receptors Market Outlook: Product
- 3.3.1. Introduction / Key Findings
- 3.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Product, 2018 - 2022
- 3.3.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
  - 3.3.3.1. Cell Lines
  - 3.3.3.2. Detection Kits
  - 3.3.3.3. Cell Culture Reagents
  - 3.3.3.4. Ligands
3.4. Market Attractiveness Analysis: Product
3.5. Global G-Protein Coupled Receptors Market Outlook: Assay Type
- 3.5.1. Introduction / Key Findings
- 3.5.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Assay Type, 2018 - 2022
- 3.5.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Assay Type, 2023 - 2030
  - 3.5.3.1. cAMP Functional Assays
  - 3.5.3.2. Calcium Functional Assays
  - 3.5.3.3. B-Arrestin Functional Assays
  - 3.5.3.4. Radioligand Binding & GTPγS Functional Assays
  - 3.5.3.5. Internalization Assays
  - 3.5.3.6. Trafficking Assays
  - 3.5.3.7. Other Assays
3.6. Market Attractiveness Analysis: Assay Type
3.7. Global G-Protein Coupled Receptors Market Outlook: Application
- 3.7.1. Introduction / Key Findings
- 3.7.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Application, 2018 - 2022
- 3.7.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
  - 3.7.3.1. Cancer Research
  - 3.7.3.2. CNS Research
  - 3.7.3.3. Metabolic Research
  - 3.7.3.4. Cardiovascular Research
  - 3.7.3.5. Respiratory Research
  - 3.7.3.6. Inflammation Research
  - 3.7.3.7. Other Applications
3.8. Market Attractiveness Analysis: Application

4. Global G-Protein Coupled Receptors Market Outlook: Region

4.1. Key Highlights
4.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Region, 2018 - 2022
4.3. Current Market Size (US$ Mn) and Volume (Units) Forecast By Region, 2023 - 2030
- 4.3.1. North America
- 4.3.2. Europe
- 4.3.3. East Asia
- 4.3.4. South Asia and Oceania
- 4.3.5. Latin America
- 4.3.6. Middle East & Africa (MEA)
4.4. Market Attractiveness Analysis: Region

5. North America G-Protein Coupled Receptors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

5.1. Key Highlights
5.2. Pricing Analysis
5.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 5.3.1. By Country
- 5.3.2. By Product
- 5.3.3. By Assay Type
- 5.3.4. By Application
5.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 5.4.1. U.S.
- 5.4.2. Canada
5.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 5.5.1. Cell Lines
- 5.5.2. Detection Kits
- 5.5.3. Cell Culture Reagents
- 5.5.4. Ligands
5.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Assay Type, 2023 - 2030
- 5.6.1. cAMP Functional Assays
- 5.6.2. Calcium Functional Assays
- 5.6.3. B-Arrestin Functional Assays
- 5.6.4. Radioligand Binding & GTPγS Functional Assays
- 5.6.5. Internalization Assays
- 5.6.6. Trafficking Assays
- 5.6.7. Other Assays
5.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 5.7.1. Cancer Research
- 5.7.2. CNS Research
- 5.7.3. Metabolic Research
- 5.7.4. Cardiovascular Research
- 5.7.5. Respiratory Research
- 5.7.6. Inflammation Research
- 5.7.7. Other Applications
5.8. Market Attractiveness Analysis

6. Europe G-Protein Coupled Receptors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

6.1. Key Highlights
6.2. Pricing Analysis
6.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 6.3.1. By Country
- 6.3.2. By Product
- 6.3.3. By Assay Type
- 6.3.4. By Application
6.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 6.4.1. Germany
- 6.4.2. France
- 6.4.3. U.K.
- 6.4.4. Italy
- 6.4.5. Spain
- 6.4.6. Russia
- 6.4.7. Turkiye
- 6.4.8. Rest of Europe
6.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 6.5.1. Cell Lines
- 6.5.2. Detection Kits
- 6.5.3. Cell Culture Reagents
- 6.5.4. Ligands
6.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Assay Type, 2023 - 2030
- 6.6.1. cAMP Functional Assays
- 6.6.2. Calcium Functional Assays
- 6.6.3. B-Arrestin Functional Assays
- 6.6.4. Radioligand Binding & GTPγS Functional Assays
- 6.6.5. Internalization Assays
- 6.6.6. Trafficking Assays
- 6.6.7. Other Assays
6.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 6.7.1. Cancer Research
- 6.7.2. CNS Research
- 6.7.3. Metabolic Research
- 6.7.4. Cardiovascular Research
- 6.7.5. Respiratory Research
- 6.7.6. Inflammation Research
- 6.7.7. Other Applications
6.8. Market Attractiveness Analysis

7. East Asia G-Protein Coupled Receptors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

7.1. Key Highlights
7.2. Pricing Analysis
7.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 7.3.1. By Country
- 7.3.2. By Product
- 7.3.3. By Assay Type
- 7.3.4. By Application
7.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 7.4.1. China
- 7.4.2. Japan
- 7.4.3. South Korea
7.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 7.5.1. Cell Lines
- 7.5.2. Detection Kits
- 7.5.3. Cell Culture Reagents
- 7.5.4. Ligands
7.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Assay Type, 2023 - 2030
- 7.6.1. cAMP Functional Assays
- 7.6.2. Calcium Functional Assays
- 7.6.3. B-Arrestin Functional Assays
- 7.6.4. Radioligand Binding & GTPγS Functional Assays
- 7.6.5. Internalization Assays
- 7.6.6. Trafficking Assays
- 7.6.7. Other Assays
7.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 7.7.1. Cancer Research
- 7.7.2. CNS Research
- 7.7.3. Metabolic Research
- 7.7.4. Cardiovascular Research
- 7.7.5. Respiratory Research
- 7.7.6. Inflammation Research
- 7.7.7. Other Applications
7.8. Market Attractiveness Analysis

8. South Asia & Oceania G-Protein Coupled Receptors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

8.1. Key Highlights
8.2. Pricing Analysis
8.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 8.3.1. By Country
- 8.3.2. By Product
- 8.3.3. By Assay Type
- 8.3.4. By Application
8.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 8.4.1. India
- 8.4.2. Southeast Asia
- 8.4.3. ANZ
- 8.4.4. Rest of South Asia & Oceania
8.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 8.5.1. Cell Lines
- 8.5.2. Detection Kits
- 8.5.3. Cell Culture Reagents
- 8.5.4. Ligands
8.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Assay Type, 2023 - 2030
- 8.6.1. cAMP Functional Assays
- 8.6.2. Calcium Functional Assays
- 8.6.3. B-Arrestin Functional Assays
- 8.6.4. Radioligand Binding & GTPγS Functional Assays
- 8.6.5. Internalization Assays
- 8.6.6. Trafficking Assays
- 8.6.7. Other Assays
8.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 8.7.1. Cancer Research
- 8.7.2. CNS Research
- 8.7.3. Metabolic Research
- 8.7.4. Cardiovascular Research
- 8.7.5. Respiratory Research
- 8.7.6. Inflammation Research
- 8.7.7. Other Applications
8.8. Market Attractiveness Analysis

9. Latin America G-Protein Coupled Receptors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

9.1. Key Highlights
9.2. Pricing Analysis
9.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 9.3.1. By Country
- 9.3.2. By Product
- 9.3.3. By Assay Type
- 9.3.4. By Application
9.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 9.4.1. Brazil
- 9.4.2. Mexico
- 9.4.3. Rest of Latin America
9.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 9.5.1. Cell Lines
- 9.5.2. Detection Kits
- 9.5.3. Cell Culture Reagents
- 9.5.4. Ligands
9.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Assay Type, 2023 - 2030
- 9.6.1. cAMP Functional Assays
- 9.6.2. Calcium Functional Assays
- 9.6.3. B-Arrestin Functional Assays
- 9.6.4. Radioligand Binding & GTPγS Functional Assays
- 9.6.5. Internalization Assays
- 9.6.6. Trafficking Assays
- 9.6.7. Other Assays
9.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 9.7.1. Cancer Research
- 9.7.2. CNS Research
- 9.7.3. Metabolic Research
- 9.7.4. Cardiovascular Research
- 9.7.5. Respiratory Research
- 9.7.6. Inflammation Research
- 9.7.7. Other Applications
9.8. Market Attractiveness Analysis

10. Middle East & Africa G-Protein Coupled Receptors Market Outlook: Historical (2018 - 2022) and Forecast (2023 - 2030)

10.1. Key Highlights
10.2. Pricing Analysis
10.3. Historical Market Size (US$ Mn) and Volume (Units) Analysis By Market, 2018 - 2022
- 10.3.1. By Country
- 10.3.2. By Product
- 10.3.3. By Assay Type
- 10.3.4. By Application
10.4. Current Market Size (US$ Mn) and Volume (Units) Forecast By Country, 2023 - 2030
- 10.4.1. GCC
- 10.4.2. Egypt
- 10.4.3. South Africa
- 10.4.4. Northern Africa
- 10.4.5. Rest of Middle East & Africa
10.5. Current Market Size (US$ Mn) and Volume (Units) Forecast By Product, 2023 - 2030
- 10.5.1. Cell Lines
- 10.5.2. Detection Kits
- 10.5.3. Cell Culture Reagents
- 10.5.4. Ligands
10.6. Current Market Size (US$ Mn) and Volume (Units) Forecast By Assay Type, 2023 - 2030
- 10.6.1. cAMP Functional Assays
- 10.6.2. Calcium Functional Assays
- 10.6.3. B-Arrestin Functional Assays
- 10.6.4. Radioligand Binding & GTPγS Functional Assays
- 10.6.5. Internalization Assays
- 10.6.6. Trafficking Assays
- 10.6.7. Other Assays
10.7. Current Market Size (US$ Mn) and Volume (Units) Forecast By Application, 2023 - 2030
- 10.7.1. Cancer Research
- 10.7.2. CNS Research
- 10.7.3. Metabolic Research
- 10.7.4. Cardiovascular Research
- 10.7.5. Respiratory Research
- 10.7.6. Inflammation Research
- 10.7.7. Other Applications
10.8. Market Attractiveness Analysis

11. Competition Landscape

11.1. Market Share Analysis, 2022
11.2. Market Structure
- 11.2.1. Competition Intensity Mapping By Market
- 11.2.2. Competition Analog IC
- 11.2.3. Apparent Product Capacity
11.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
- 11.3.1. Thermo Fisher Scientific Inc.
  - 11.3.1.1. Overview
  - 11.3.1.2. Segments and Product
  - 11.3.1.3. Key Financials
  - 11.3.1.4. Market Developments
  - 11.3.1.5. Market Strategy
- 11.3.2. Eurofins Scientific
  - 11.3.2.1. Overview
  - 11.3.2.2. Segments and Product
  - 11.3.2.3. Key Financials
  - 11.3.2.4. Market Developments
  - 11.3.2.5. Market Strategy
- 11.3.3. QIAGEN
  - 11.3.3.1. Overview
  - 11.3.3.2. Segments and Product
  - 11.3.3.3. Key Financials
  - 11.3.3.4. Market Developments
  - 11.3.3.5. Market Strategy
- 11.3.4. WuXi AppTec
  - 11.3.4.1. Overview
  - 11.3.4.2. Segments and Product
  - 11.3.4.3. Key Financials
  - 11.3.4.4. Market Developments
  - 11.3.4.5. Market Strategy
- 11.3.5. Promega Corporation
  - 11.3.5.1. Overview
  - 11.3.5.2. Segments and Product
  - 11.3.5.3. Key Financials
  - 11.3.5.4. Market Developments
  - 11.3.5.5. Market Strategy
- 11.3.6. Abcam plc
  - 11.3.6.1. Overview
  - 11.3.6.2. Segments and Product
  - 11.3.6.3. Key Financials
  - 11.3.6.4. Market Developments
  - 11.3.6.5. Market Strategy
- 11.3.7. Merck KGaA
  - 11.3.7.1. Overview
  - 11.3.7.2. Segments and Product
  - 11.3.7.3. Key Financials
  - 11.3.7.4. Market Developments
  - 11.3.7.5. Market Strategy
- 11.3.8. PerkinElmer Inc.
  - 11.3.8.1. Overview
  - 11.3.8.2. Segments and Product
  - 11.3.8.3. Key Financials
  - 11.3.8.4. Market Developments
  - 11.3.8.5. Market Strategy
- 11.3.9. Enzo Biochem Inc.
  - 11.3.9.1. Overview
  - 11.3.9.2. Segments and Product
  - 11.3.9.3. Key Financials
  - 11.3.9.4. Market Developments
  - 11.3.9.5. Market Strategy
- 11.3.10. Becton, Dickinson and Company
  - 11.3.10.1. Overview
  - 11.3.10.2. Segments and Product
  - 11.3.10.3. Key Financials
  - 11.3.10.4. Market Developments
  - 11.3.10.5. Market Strategy

12. Appendix

12.1. Research Methodology
12.2. Research Assumptions
12.3. Acronyms and Abbreviations